Key result
High NIRV score flags RV disease more sensitively than WHO-FC and links to ~2.6-fold higher mortality.
Why the study?
In suspected PH, functional limitation may reflect both RV involvement and non-RV comorbidity, motivating the development of a non-invasive score integrating RV-pulmonary arterial coupling and myocardial stress to identify objective RV disease and provide prognostic information beyond WHO functional class.
Does the Non-Invasive Right Ventricular (NIRV) score and its TAPSE/PASP-defined binary classification identify objective echocardiographic right ventricular disease and predict all-cause mortality compared with WHO functional class in adults with suspected pulmonary hypertension?
Cohort (n=379)
No
Does the Non-Invasive Right Ventricular (NIRV) score and its TAPSE/PASP-defined binary classification identify objective echocardiographic right ventricular disease and predict all-cause mortality compared with WHO functional class in adults with suspected pulmonary hypertension?
In patients with suspected pulmonary hypertension, a TAPSE/PASP-defined binary classification (≤0.31 mm/mmHg) identifies objective echocardiographic right ventricular involvement with higher sensitivity than WHO functional class III–IV, while the full 0–3 NIRV score (incorporating NT-proBNP ≥1400 pg/mL) provides exploratory prognostic value for all-cause mortality.
Answers are grounded in this paper and cite their sources.
May aid RV disease detection in suspected PH beyond functional class; hypothesis-generating for prognosis, requiring prospective validation.
Background/Objectives: In suspected pulmonary hypertension (PH), functional limitation may reflect right ventricular (RV) involvement and non-RV comorbidity. We developed the Non-Invasive Right Ventricular (NIRV) score, integrating RV–pulmonary arterial coupling and myocardial stress, to identify objective RV disease and assess prognostic information beyond World Health Organization functional class (WHO-FC). Methods: This single-centre retrospective cohort included consecutive adults evaluated for suspected PH. NIRV assigns 2 points for tricuspid annular plane systolic excursion to pulmonary artery systolic pressure ratio (TAPSE/PASP) ≤0.31 mm/mmHg and 1 point for N-terminal pro–B-type natriuretic peptide (NT-proBNP) ≥1400 pg/mL, yielding a 0–3 score. Thus, binary NIRV classification (0–1 vs. 2–3) depends exclusively on TAPSE/PASP ≤ 0.31 mm/mmHg. Objective RV disease required abnormalities in at least two of three prespecified echocardiographic domains and was defined independently of WHO-FC, TAPSE/PASP, NT-proBNP, and NIRV-derived classifications. Results: Of 490 patients, 379 had an available NIRV score, and objective RV disease was evaluable in 379 patients, of whom 158 (41.7%) met the echocardiographic RV involvement criteria. Among 358 patients with valid WHO-FC data, TAPSE/PASP-defined classification showed higher sensitivity (77.5% vs. 35.8%) but lower specificity (61.8% vs. 75.8%) than WHO-FC III–IV. In the 379-patient cohort, the AUC increased only marginally when continuous NT-proBNP was added to TAPSE/PASP (0.777 to 0.782). WHO-low/NIRV-high discordance occurred in 126/361 (34.9%); 71/126 with outcome data (56.3%) had objective RV disease. The date-complete survival cohort included 379 patients (140 deaths), with a median follow-up of 727 days. In the clinically adjusted Cox model (n = 354; 128 deaths), NIRV 3 was associated with higher mortality hazard than NIRV 0 (HR, 2.59; 95% CI, 1.46–4.59), although the association across score categories was nonmonotonic. Conclusions: The TAPSE/PASP-defined binary NIRV classification was associated with the study-defined echocardiographic RV involvement phenotype, whereas the full 0–3 score retained information from both physiological components. Categorical NIRV was associated with all-cause mortality in exploratory Cox analyses, without a monotonic mortality gradient. Prospective external validation is required before use.
No takes yet. Share an insight, caveat, or question.
Rubio et al. (2026) conducted a cohort in Suspected pulmonary hypertension (n=379). Non-Invasive Right Ventricular (NIRV) score (integrating TAPSE/PASP <=0.31 mm/mmHg and NT-proBNP >=1400 pg/mL) vs. NIRV 0 or World Health Organization functional class (WHO-FC) was evaluated on All-cause mortality (NIRV 3 vs NIRV 0) and objective echocardiographic right ventricular disease (HR 2.59, 95% CI 1.46-4.59). The NIRV score identified objective RV disease with higher sensitivity than WHO-FC III-IV, and NIRV 3 vs 0 predicted higher mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: